
Loading, please wait...

Loading, please wait...

IDEAL-ICU examined whether renal-replacement therapy should be started early in patients with septic shock and severe acute kidney injury who did not yet have a life-threatening indication for dialysis. Patients were randomised to an early strategy or a delayed strategy in which renal replacement was deferred for 48 hours if kidney function did not recover. The trial was stopped early because of slow recruitment and did not demonstrate a survival advantage for the early strategy. A meaningful proportion of patients assigned to the delayed group recovered renal function without dialysis. These findings reinforced the principle that laboratory severity alone should not automatically trigger immediate renal-replacement therapy. For the intensivist, the decision should integrate urine output, acid-base status, potassium, fluid balance, uraemic complications and the trajectory of kidney recovery. IDEAL-ICU is especially relevant in septic shock, where patients often have rapidly changing haemodynamics and may recover kidney function once perfusion and infection are controlled. Starting renal replacement too early can expose patients to catheter complications, anticoagulation and treatment-related haemodynamic instability without improving outcomes. The trial therefore supports selective timing rather than a fixed “early” threshold, while reminding clinicians that patients with clear emergency indications should not be delayed simply because they are in a protocol designed to test timing.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


IDEAL-ICU examined whether renal-replacement therapy should be started early in patients with septic shock and severe acute kidney injury who did not yet have a life-threatening indication for dialysis. Patients were randomised to an early strategy or a delayed strategy in which renal replacement was deferred for 48 hours if kidney function did not recover. The trial was stopped early because of slow recruitment and did not demonstrate a survival advantage for the early strategy. A meaningful proportion of patients assigned to the delayed group recovered renal function without dialysis. These findings reinforced the principle that laboratory severity alone should not automatically trigger immediate renal-replacement therapy. For the intensivist, the decision should integrate urine output, acid-base status, potassium, fluid balance, uraemic complications and the trajectory of kidney recovery. IDEAL-ICU is especially relevant in septic shock, where patients often have rapidly changing haemodynamics and may recover kidney function once perfusion and infection are controlled. Starting renal replacement too early can expose patients to catheter complications, anticoagulation and treatment-related haemodynamic instability without improving outcomes. The trial therefore supports selective timing rather than a fixed “early” threshold, while reminding clinicians that patients with clear emergency indications should not be delayed simply because they are in a protocol designed to test timing.
last month

Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back

An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
2 days back

Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
2 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week